Rameen Beroukhim, M.D., Ph.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Rameen Beroukhim, M.D., Ph.D., Dana-Farber Cancer Institute

Caption

Rameen Beroukhim, M.D., Ph.D., and colleagues found that the newly identified "CYCLOPS" genes may serve as targets for cancer therapies.

Credit

Sam Ogden

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.